Amundi Asset Management US’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-258,176
| Closed | -$6.41M | – | 1691 |
|
|
2019
Q1 | $6.41M | Sell |
258,176
-6,924
| -3% | -$172K | 0.01% | 803 |
|
|
2018
Q4 | $4.76K | Sell |
265,100
-107,200
| -29% | -$1.93K | ﹤0.01% | 840 |
|
|
2018
Q3 | $10.9M | Buy |
372,300
+89,000
| +31% | +$2.61M | 0.01% | 713 |
|
|
2018
Q2 | $12.9M | Buy |
283,300
+84,300
| +42% | +$3.83M | 0.02% | 654 |
|
|
2018
Q1 | $10.5M | Buy |
199,000
+146,200
| +277% | +$7.72M | 0.02% | 668 |
|
|
2017
Q4 | $3.59M | Buy |
+52,800
| New | +$3.59M | 0.01% | 934 |
|